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Background:  We sought to study the prognostic utility of serum brain natriuretic peptide (BNP) in patients with significant myxomatous 
mitral regurgitation (MMR) & normal left ventricular ejection fraction (LVEF).
methods:  548 patients (age 62±13 years & 66% men) with ≥3+ MMR & normal LVEF on resting echo, evaluated at our center between 
2005-8 were studied. Baseline clinical & echo data was recorded & Society of Thoracic Surgeons (STS) score was calculated. Primary 
outcome was cardiac death.
results:  Mean STS score was 4±1%. 42% were in functional class (FC) I &36% in FC II; 30% had atrial fibrillation (AF). Mean LVEF, 
mitral effective regurgitant orifice, indexed LV end-systolic diameter (LVESD) & right ventricular systolic pressure (RVSP) were 60±4%, 
0.50±0.2 cm2, 1.6±0.3 cm/m2 & 38±15 mm Hg; 43% had flail. Mean log transformed BNP (lnBNP) was 4.2±1.2 (13% had an absolute BNP 
value>250 pg/ml). At 7.4±2 years, 493 patients (90%) had mitral surgery (92% repair) & death occurred in 53 patients (10%). On stepwise 
multivariable Cox analysis, STS score (HR 1.50 [1.20-1.88]), baseline RVSP (HR 1.17 [1.02-1.35]), mitral surgery (HR 0.17 [0.09-0.30]) & 
lnBNP (HR 2.51 [1.86-3.39], also figure) predicted death (all p<0.01). Addition of ln-BNP to STS score, mitral surgery & RVSP resulted in 
net reclassification improvement (0.3 [0.17-0.44], p<0.001). 89% deaths occurred in patients with lnBNP >4.1.
conclusion:  In patients with ≥3+ MMR & normal EF, higher BNP predicted reduced survival & improved risk stratification 
